期刊文献+

慢性丙型肝炎中医证型与HCV 1b亚型NS5A aa变异、IL28B SNP的关系 被引量:4

Relationship between TCM syndromes and amino acid mutation in NS5A aa,IL28B SNP of chronic HCV 1b infection
下载PDF
导出
摘要 目的分析慢性丙型肝炎(CHC)中医证型与患者一般情况、肝功能、HCV RNA、NS5A aa变异及IL28B SNP的关系。方法通过回顾性研究,收集58例CHC患者的一般临床资料、血生化(ALT、AST、ALB、GLO、TBIL)、HCV RNA、NS5A aa变异及IL28B SNP,Spss 19.0软件分析各数据与中医证型的相关性。结果 58例CHC中医证型中,正虚邪恋型最多(43.1%),中医证型与年龄和球蛋白有关(P<0.05),肝郁脾虚型多见于年轻患者,瘀血阻络型和肝肾阴虚型多见于中老年患者。中医证型与HCV RNA、NS5A aa变异及IL28B SNP无统计学意义(P>0.05)。结论 CHC中医证型中,正虚邪恋型最多,中医证型与年龄和球蛋白有关,与HCV RNA、NS5A aa变异以及IL28B SNP无关。 Objective To analyze the relationship between traditional Chinese medicine( TCM) syndromes and clinical data,liver function,HCV RNA,amino acid mutation in NS5 A and IL28 B SNP of chronic HCV 1b infection. Methods A total of 58 patients were analyzed retrospectively. To collect their clinical data,biochemistry( ALT,AST,ALB,GLO,TBIL),HCV RNA,mutation in NS5 A and IL28 B SNP. The correlations between TCM syndromes and data were analysised using the SPSS 19. 0 software. Results Among 58 patients enrolled in this study,the pattern of deficient vital QI leading to lingering of pathogen was maximum( 43. 1%). We identified that age and GLO were related to TCM syndromes( P〈0. 05),the majority patients of pattern of stagnation of liver-qi with deficiency of the spleen were younger,and the majority patients of obstruction of collaterals by blood stasis and yin deficiency of liver and kindey were older. There was no significant correlation was observed between the TCM syndromes and HCV RNA,amino acid mutation in NS5 A,IL28B SNP( P〉0. 05). Conclusion There may be some relationship between TCM symptoms and objective indexes in patients with CHC,TCM syndrome type have related with age and protein,but no related with HCV RNA NS5 A aa and IL28 B SNP.
出处 《长春中医药大学学报》 2015年第4期762-765,共4页 Journal of Changchun University of Chinese Medicine
基金 陕西省教育厅课题"丙肝合剂抗丙型肝炎病毒的实验研究"(2013JK0815) 咸阳市科技局课题"PKRBD/ISDR变异和IL28B SNPs多态性对HCV1b亚型患者抗病毒疗效的影响"(2014K04-04) 陕西中医学院课题"PKRBD/ISDR变异和IL28B SNPs多态性对HCV1b亚型患者抗病毒疗效的影响"(14XJZR08) 陕西中医学院附属医院课题"丙肝合剂对HCV复制子RNA和NS5A蛋白表达的影响"(2014-34)
关键词 慢性丙型肝炎 中医证型 基因分型 HCV RNA chronic hepatitis C traditional Chinese medicine syndrome genotyping HCV RNA
  • 相关文献

参考文献20

  • 1丙型肝炎防治指南[J].中华传染病杂志,2004,22(2):131-136. 被引量:225
  • 2ENOMOTO N,SAKUMA I,ASAHINA Y,et al.Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b.Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region[J].The Journal of Clinical Investigation,1995,96(1):224-230.
  • 3GALE M J,KORTH M J,TANG N-m,et al.Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein[J].Virology,1997,230(2):217-227.
  • 4VEILLON P,PAYAN C,GAUDY C,et al.Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin[J].Pathologie Biologie,2004,52(9):505-510.
  • 5EL-SHAMY A,NAGANO-FUJII M,SASASE N,et al.Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy[J].Hepatology(Baltimore,Md.),2008,48(1):38-47.
  • 6EL-SHAMY A,SHOJI I,SAITO T,et al.Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy[J].Microbiology and Immunology,2011,55(6):418-426.
  • 7GE DONGLIANG,FELLAY J,THOMPSON A J,et al.Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance[J].Nature,2009,461(7262):399-401.
  • 8SUPPLIAH,V.IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy[J].Nature Genetics,2009,41(10):1100-1104.
  • 9SUPPIAH V,MOLDOVAN M,AHLENSTIEL G,et al.IL28B is associated with response to chronic hepatitis C interferon-αand ribavirin therapy[J].Nature genetics,2009,41(10):1100-1104.
  • 10TANAKA Y,NISHIDA NAO,SUGIYAMA M,et al.Genomewide association of IL28B with response to pegylated interferonalpha and ribavirin therapy for chronic hepatitis C[J].Nature Genetics,2009,41(10):1105-1109.

二级参考文献104

共引文献306

同被引文献79

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部